DOCSLIB.ORG

The Role of Sirtuin 2 Activation by Nicotinamide Phosphoribosyltransferase in the Aberrant Proliferation and Survival of Myeloid Leukemia Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Acute Myeloid Leukemia Articles and Brief Reports The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells Lan Dan, 1,4 Olga Klimenkova, 1 Maxim Klimiankou, 1 Jan-Henning Klusman, 2 Marry M. van den Heuvel-Eibrink, 3 Dirk Reinhardt, 2 Karl Welte, 1 and Julia Skokowa 1 1Department of Molecular Hematopoiesis, Children’s Hospital, Hannover Medical School, Hannover, Germany; 2Department of Pediatric Hematology and Oncology, Children’s Hospital, Hannover Medical School, Hannover, Germany; and 3Department of Pediatric Oncology and Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands; 4Department of Pediatrics, The First Affiliated Hospital of GuangXi Medical University, NanNing, China ABSTRACT Acknowledgments: we thank Background A. Gigina, A. Müller Brechlin Inhibitors of nicotinamide phosphoribosyltransferase have recently been validated as therapeu - and M. Reuter for their excellent tic targets in leukemia, but the mechanism of leukemogenic transformation downstream of this technical assistance. enzyme is unclear. Manuscript received on Design and Methods September 14, 2011. Revised version arrived on November 21, Here, we evaluated whether nicotinamide phosphoribosyltransferase’s effects on aberrant pro - 2011. Manuscript accepted liferation and survival of myeloid leukemic cells are dependent on sirtuin and delineated the on December 19, 2011. downstream signaling pathways operating during this process. Correspondence: Results Karl Welte, Department of We identified significant upregulation of sirtuin 2 and nicotinamide phosphoribosyltransferase Molecular Hematopoiesis, Hannover levels in primary acute myeloid leukemia blasts compared to in hematopoietic progenitor cells Medical School, Carl-Neuberg from healthy individuals. Importantly, specific inhibition of nicotinamide phosphoribosyltrans - Str. 1, 30625 Hannover, ferase or sirtuin 2 significantly reduced proliferation and induced apoptosis in human acute Germany. myeloid leukemia cell lines and primary blasts. Intriguingly, we found that protein kinase E-mail: B/AKT could be deacetylated by nicotinamide phosphoribosyltransferase and sirtuin 2. The [email protected] anti-leukemic effects of the inhibition of nicotinamide phosphoribosyltransferase or sirtuin 2 were accompanied by acetylation of protein kinase B/AKT with subsequent inhibition by de- Skokowa Julia, Department of phosphorylation. This leads to activation of glycogen synthase kinase-3 via diminished phos - Molecular Hematopoiesis, Hannover β Medical School, Carl-Neuberg-Str. phorylation and, ultimately, inactivation of β-catenin by phosphorylation. 1, 30625 Hannover, Germany. Conclusions E-mail: [email protected] Our results provide strong evidence that nicotinamide phosphoribosyltransferase and sirtuin 2 participate in the aberrant proliferation and survival of leukemic cells, and suggest that the pro - The online version of this article tein kinase B/AKT/ glycogen synthase kinase-3 β/β-catenin pathway is a target for inhibition of has a Supplementary Appendix. nicotinamide phosphoribosyltransferase or sirtuin 2 and, thereby, leukemia cell proliferation. Key words: Nampt, SIRT2, Akt, GSK3, acute myeloid leukemia , acetylation. Citation: Dan L, Klimenkova O, Klimiankou M, Klusman J-H, van den Heuvel-Eibrink MM, Reinhardt D, Welte K, and Skokowa J. The role of sirtuin 2 activation by nicotinamide phosphoribo - syltransferase in the aberrant proliferation and survival of myeloid leukemia cells. Haematologica 2012;97(4):551-559. doi:10.3324/haematol.2011.055236 ©2012 Ferrata Storti Foundation. This is an open-access paper. haematologica | 2012; 97(4) 551 l. Dan et al. Introduction B-cell neoplasia and multiple myeloma. 27-32 Here, we aimed to evaluate the involvement of NAMPT Recently, we demonstrated that nicotinamide phospho - and SIRT2 in the aberrant proliferation and survival of ribosyltransferase (NAMPT) is an essential enzyme medi - leukemic cells, and to ascertain whether the ator of granulocyte colony-stimulating factor (G-CSF)- AKT/GSK3 β/β-catenin signaling pathway plays a role in triggered granulopoiesis. 1 NAMPT is the rate-limiting mediating this process. enzyme in the biosynthesis of NAD + and supplies NAD + to sirtuins, which require NAD + to activate their protein deacetylase functions. 2 In vitro stimulation of CD34 + cells Design and Methods with NAMPT leads to granulocytic differentiation via SIRT1-C/EBP (CCAAT/enhancer binding protein)-depen - Patients and control subjects dent activation of autocrine G-CSF synthesis and G-CSF Primary blasts from 11 patients with AML and CD34 + bone receptor expression in myeloid cells. 1 In addition, a specif - marrow cells from six healthy individuals were isolated from bone ic inhibitor of NAMPT has been validated as a therapeutic marrow mononuclear cells by Ficoll-Hypaque gradient centrifuga - target in leukemia, 3 suggesting that different mechanisms tion and were subsequently sorted using MACS beads. We operate downstream of NAMPT in “normal” and leuke - obtained approval for this study from Hannover Medical School’s mogenic myeloid cells. However, the mechanisms down - institutional review board. Informed consent was obtained from stream of NAMPT which are responsible for the aberrant the study participants in accordance with the Declaration of proliferation and apoptosis of leukemic cells have Helsinki. remained elusive. Sirtuins are members of the NAD +-dependent class III Cell lines and culture conditions histone deacetylase family; seven members (SIRT1-7) of NB4 and HL60 AML cell lines were cultured in RPMI-1640 this family have been described in humans. Sirtuins pos - medium with 10% fetal calf serum and 1% penicillin/strepto - sess either histone or protein deacetylase activity, and play mycin. CD34 + cells from healthy individuals and AML blasts were a particularly important role in the response to certain cultured for 4 days in 24-well tissue-culture plates (2 ¥10 5 types of stress and toxicity. Sirtuins are involved in life - cells/well) in X-vivo medium supplemented with 1% heat-inacti - span extension, age-related disorders, obesity, heart dis - vated autologous human serum with 20 ng/mL of interleukin-3, 20 ease, neurological function and cancer. 4 SIRT1, one of the ng/mL of interleukin-6, 20 ng/mL of thrombopoietin, 50 ng/mL of most extensively studied sirtuins, is known to deacetylate, stem cell factor and 50 ng/mL of Flt3 ligand. and thereby inactivate, p53 and FOXO3a. 5 SIRT2, unlike SIRT1, is mostly found in the cytoplasm 2 and shows cell Assessment of cell proliferation, cell cycle and apoptosis cycle-dependent intracellular localization, undergoing Cells (2 ¥10 4/100 mL) were plated in 96-well plates and incubated rapid nucleo-cytoplasmic shifts during G2/M cell-cycle with different concentrations of FK866 or AC 93253 for the indi - progression. This observation together with the demon - cated times. We used the CellTiter-Glo Luminescence Cell stration that overexpression of SIRT2 mediates a delay in Proliferation Assay to assess cell proliferation. To analyze apopto - cellular proliferation 6 suggest that SIRT2 may play a role in sis we used the Caspase-Glo 3/7 Activity Assay and counted cell-cycle regulation. The importance of nucleo-cytoplas - viable cells using trypan blue dye exclusion. Both assays were per - mic shuttling in SIRT2 function is highlighted by the formed according to the manufacturer’s instructions (Promega). observation that abnormal intracellular SIRT2 localization For cell cycle analysis we measured BrdU uptake (20 min) using a may lead to pathological downstream effects, such as BrdU Flow Kit (Pharmingen). abnormal cellular response of leukemic cells to DNA dam - age. 7 SIRT2 also deacetylates α-tubulin, 6,8 suggesting a Quantitative reverse transcriptase polymerase function in cytoskeletal organization. In addition to target - chain reaction analysis ing α-tubulin, SIRT2 is known to specifically target NF- We isolated RNA using a RNeasy Mini Kit, amplified cDNA kB, 9 FOXO transcription factors 10-12 and p53. 13-15 with random hexamer primers and a cDNA synthesis kit (Qiagen). The AKT pathway is frequently activated in acute We measured mRNA expression using a SYBR green qPCR kit. myeloid leukemia (AML). 16-18 However, the mechanisms Target gene mRNA expression was normalized to β-actin and was leading to AKT activation in AML are not completely represented as arbitrary units (AU). Primer sequences are available clear. NAMPT (visfatin) has recently been shown to on request. induce AKT phosphorylation in endothelial cells and in cardiac fibroblasts. 19,20 AKT phosphorylates and thereby Western blot analysis inhibits a serine-threonine kinase glycogen synthase We used mouse anti- β-actin, rabbit anti-AKT, rabbit anti-phos - kinase 3 β (GSK3 β). 21 GSK3 β is a well-known inhibitor of pho-AKT (Ser473) (193H12), rabbit anti-GSK-3 β (27 C10 ), and rab - Wnt signaling. GSK3 β targets the proto-oncogene β- bit anti-phospho-GSK-3 β (Ser9 ) (5 B3 ) ( all from Cell Signaling catenin and promotes its ubiquitination and proteasome- Technology ). Horseradish peroxidase-conjugated anti-mouse or mediated degradation. 22,23 Inactivation of GSK3 β leads to anti-rabbit secondary antibodies (Santa Cruz Biotechnology) were β-catenin accumulation and redistribution to the nucle - used as appropriate. We obtained whole-cell lysates through direct us. 22,23 Nuclear β-catenin interacts with LEF-1/TCF
Recommended publications
  • Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence

    Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence

    International Journal of Molecular Sciences Article Understanding the Potential Role of Sirtuin 2 on Aging: Consequences of SIRT2.3 Overexpression in Senescence Noemi Sola-Sevilla 1, Ana Ricobaraza 2, Ruben Hernandez-Alcoceba 2 , Maria S. Aymerich 3,4, Rosa M. Tordera 1 and Elena Puerta 1,* 1 Pharmacology and Toxicology Department, Faculty of Pharmacy, University of Navarra, Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain; [email protected] (N.S.-S.); [email protected] (R.M.T.) 2 Gene Therapy Program CIMA, University of Navarra, Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain; [email protected] (A.R.); [email protected] (R.H.-A.) 3 Departamento de Bioquímica y Genética, Facultad de Ciencias, Universidad de Navarra, 31008 Pamplona, Spain; [email protected] 4 Neuroscience Program CIMA, University of Navarra, Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain * Correspondence: [email protected] Abstract: Sirtuin 2 (SIRT2) has been associated to aging and age-related pathologies. Specifically, an age-dependent accumulation of isoform 3 of SIRT2 in the CNS has been demonstrated; however, no study has addressed the behavioral or molecular consequences that this could have on aging. In the present study, we have designed an adeno-associated virus vector (AAV-CAG-Sirt2.3-eGFP) for the overexpression of SIRT2.3 in the hippocampus of 2 month-old SAMR1 and SAMP8 mice. Our Citation: Sola-Sevilla, N.; results show that the specific overexpression of this isoform does not induce significant behavioral or Ricobaraza, A.; Hernandez-Alcoceba, molecular effects at short or long term in the control strain. Only a tendency towards a worsening in R.; Aymerich, M.S.; Tordera, R.M.; the performance in acquisition phase of the Morris Water Maze was found in SAMP8 mice, together Puerta, E.
  • Dynamic Metabolic Zonation of the Hepatic Glucose Metabolism Is Accomplished by Sinusoidal Plasma Gradients of Nutrients and Hormones

    Dynamic Metabolic Zonation of the Hepatic Glucose Metabolism Is Accomplished by Sinusoidal Plasma Gradients of Nutrients and Hormones

    ORIGINAL RESEARCH published: 12 December 2018 doi: 10.3389/fphys.2018.01786 Dynamic Metabolic Zonation of the Hepatic Glucose Metabolism Is Accomplished by Sinusoidal Plasma Gradients of Nutrients and Hormones Nikolaus Berndt 1,2 and Hermann-Georg Holzhütter 1* 1 Computational Biochemistry Group, Institute of Biochemistry, Charite—University Medicine Berlin, Berlin, Germany, 2 Institute for Computational and Imaging Science in Cardiovascular Medicine, Charite—University Medicine Berlin, Berlin, Germany Being the central metabolic organ of vertebrates, the liver possesses the largest repertoire of metabolic enzymes among all tissues and organs. Almost all metabolic pathways are resident in the parenchymal cell, hepatocyte, but the pathway capacities may largely differ depending on the localization of hepatocytes within the liver acinus-a phenomenon that is commonly referred to as metabolic zonation. Metabolic zonation is rather dynamic since gene expression patterns of metabolic enzymes may change in response to nutrition, Edited by: drugs, hormones and pathological states of the liver (e.g., fibrosis and inflammation). Steven Dooley, Universitätsmedizin Mannheim, This fact has to be ultimately taken into account in mathematical models aiming at Medizinische Fakultät Mannheim, the prediction of metabolic liver functions in different physiological and pathological Universität Heidelberg, Germany settings. Here we present a spatially resolved kinetic tissue model of hepatic glucose Reviewed by: metabolism which includes zone-specific temporal changes of enzyme abundances Adil Mardinoglu, Chalmers University of Technology, which are driven by concentration gradients of nutrients, hormones and oxygen along Sweden the hepatic sinusoids. As key modulators of enzyme expression we included oxygen, Rolf Gebhardt, Leipzig University, Germany glucose and the hormones insulin and glucagon which also control enzyme activities *Correspondence: by cAMP-dependent reversible phosphorylation.
  • The Sirtuin Family's Role in Aging and Age-Associated Pathologies

    The Sirtuin Family's Role in Aging and Age-Associated Pathologies

    The sirtuin family’s role in aging and age-associated pathologies Jessica A. Hall, … , Yoonjin Lee, Pere Puigserver J Clin Invest. 2013;123(3):973-979. https://doi.org/10.1172/JCI64094. Review Series The 7 mammalian sirtuin proteins compose a protective cavalry of enzymes that can be invoked by cells to aid in the defense against a vast array of stressors. The pathologies associated with aging, such as metabolic syndrome, neurodegeneration, and cancer, are either caused by or exacerbated by a lifetime of chronic stress. As such, the activation of sirtuin proteins could provide a therapeutic approach to buffer against chronic stress and ameliorate age- related decline. Here we review experimental evidence both for and against this proposal, as well as the implications that isoform-specific sirtuin activation may have for healthy aging in humans. Find the latest version: https://jci.me/64094/pdf Review series The sirtuin family’s role in aging and age-associated pathologies Jessica A. Hall, John E. Dominy, Yoonjin Lee, and Pere Puigserver Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA. The 7 mammalian sirtuin proteins compose a protective cavalry of enzymes that can be invoked by cells to aid in the defense against a vast array of stressors. The pathologies associated with aging, such as metabolic syndrome, neuro- degeneration, and cancer, are either caused by or exacerbated by a lifetime of chronic stress. As such, the activation of sirtuin proteins could provide a therapeutic approach to buffer against chronic stress and ameliorate age-related decline.
  • Chem331 Glycogen Metabolism

    Chem331 Glycogen Metabolism

    Glycogen metabolism Glycogen review - 1,4 and 1,6 α-glycosidic links ~ every 10 sugars are branched - open helix with many non-reducing ends. Effective storage of glucose Glucose storage Liver glycogen 4.0% 72 g Muscle glycogen 0.7% 245 g Blood Glucose 0.1% 10 g Large amount of water associated with glycogen - 0.5% of total weight Glycogen stored in granules in cytosol w/proteins for synthesis, degradation and control There are very different means of control of glycogen metabolism between liver and muscle Glycogen biosynthetic and degradative cycle Two different pathways - which do not share enzymes like glycolysis and gluconeogenesis glucose -> glycogen glycogenesis - biosynthetic glycogen -> glucose 1-P glycogenolysis - breakdown Evidence for two paths - Patients lacking phosphorylase can still synthesize glycogen - hormonal regulation of both directions Glycogenolysis (glycogen breakdown)- Glycogen Phosphorylase glycogen (n) + Pi -> glucose 1-p + glycogen (n-1) • Enzyme binds and cleaves glycogen into monomers at the end of the polymer (reducing ends of glycogen) • Dimmer interacting at the N-terminus. • rate limiting - controlled step in glycogen breakdown • glycogen phosphorylase - cleavage of 1,4 α glycosidic bond by Pi NOT H2O • Energy of phosphorolysis vs. hydrolysis -low standard state free energy change -transfer potential -driven by Pi concentration -Hydrolysis would require additional step s/ cost of ATP - Think of the difference between adding a phosphate group with hydrolysis • phosphorylation locks glucose in cell (imp. for muscle) • Phosphorylase binds glycogen at storage site and the catalytic site is 4 to 5 glucose residues away from the catalytic site. • Phosphorylase removes 1 residue at a time from glycogen until 4 glucose residues away on either side of 1,6 branch point – stericaly hindered by glycogen storage site • Cleaves without releasing at storage site • general acid/base catalysts • Inorganic phosphate attacks the terminal glucose residue passing through an oxonium ion intermediate.
  • Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer

    Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer

    H OH metabolites OH Review Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer Mio Harachi 1, Kenta Masui 1,* , Webster K. Cavenee 2, Paul S. Mischel 3 and Noriyuki Shibata 1 1 Department of Pathology, Division of Pathological Neuroscience, Tokyo Women’s Medical University, Tokyo 162-8666, Japan; [email protected] (M.H.); [email protected] (N.S.) 2 Ludwig Institute for Cancer Research, University of California San Diego, La Jolla, CA 92093, USA; [email protected] 3 Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; [email protected] * Correspondence: [email protected]; Tel.: +81-3-3353-8111; Fax: +81-3-5269-7408 Abstract: Metabolic reprogramming is an emerging hallmark of cancer and is driven by abnormalities of oncogenes and tumor suppressors. Accelerated metabolism causes cancer cell aggression through the dysregulation of rate-limiting metabolic enzymes as well as by facilitating the production of intermediary metabolites. However, the mechanisms by which a shift in the metabolic landscape reshapes the intracellular signaling to promote the survival of cancer cells remain to be clarified. Recent high-resolution mass spectrometry-based proteomic analyses have spotlighted that, unex- pectedly, lysine residues of numerous cytosolic as well as nuclear proteins are acetylated and that this modification modulates protein activity, sublocalization and stability, with profound impact on cellular function. More importantly, cancer cells exploit acetylation as a post-translational protein for microenvironmental adaptation, nominating it as a means for dynamic modulation of the phenotypes of cancer cells at the interface between genetics and environments.
  • And Sirtuin 2 (SIRT2) in Inhibiting Cargo- Loading and Release of Extracellular Vesicles Byung Rho Lee, Bethany J

    And Sirtuin 2 (SIRT2) in Inhibiting Cargo- Loading and Release of Extracellular Vesicles Byung Rho Lee, Bethany J

    www.nature.com/scientificreports OPEN Distinct role of Sirtuin 1 (SIRT1) and Sirtuin 2 (SIRT2) in inhibiting cargo- loading and release of extracellular vesicles Byung Rho Lee, Bethany J. Sanstrum, Yutao Liu & Sang-Ho Kwon * Exosomes, vehicles for intercellular communication, are formed intracellularly within multivesicular bodies (MVBs) and are released upon fusion with the plasma membrane. For their biogenesis, proper cargo loading to exosomes and vesicle trafc for extracellular release are required. Previously we showed that the L-type lectin, LMAN2, limits trans-Golgi Network (TGN)-to-endosomes trafc of GPRC5B, an exosome cargo protein, for exosome release. Here, we identifed that the protein deacetylase sirtuin 2 (SIRT2) as a novel interactor of LMAN2. Loss of SIRT2 expression resulted in exosomal release of LMAN2, a Golgi resident protein, along with increased exosomal release of GPRC5B. Furthermore, knockout of SIRT2 increased total number of extracellular vesicles (EVs), indicating increased MVB-to-EV fux. While knockout of SIRT1 increased EV release with enlarged late endolysosome, knockout of SIRT2 did not exhibit endolysosome enlargement for increased EV release. Taken together, our study suggests that SIRT2 regulates cargo loading to MVBs and MVB-to-EV fux through a mechanism distinct from that of SIRT1. Small extracellular vesicles (EVs) called exosomes are vehicles for intercellular communication1,2 and are involved in the progression of many human disease or protection against diseases3,4. Cargoes loaded in exosomes can range from various RNAs to growth factors and extracellular remodeling molecules3,5–7. For the communication role, select cargo loading and proper vesicle trafcking in exosome producing cells as well as retrieval of exosomes to target cells are required.
  • UNIVERSITY of CALIFORNIA, SAN DIEGO Mechanism of Pentose

    UNIVERSITY of CALIFORNIA, SAN DIEGO Mechanism of Pentose

    UNIVERSITY OF CALIFORNIA, SAN DIEGO Mechanism of Pentose Phosphate Pathway Regulation by Akt in de Novo Purine Synthesis During Essential Amino Acid Starvation A thesis submitted in partial satisfaction of the requirements for the degree Master of Science in Biology by Deron Trent Amador Committee in charge: Professor Gerard Boss, Chair Professor Eliña Zuniga, Co-Chair Professor Elvira Tour 2012 The Thesis of Deron Trent Amador is approved and it is acceptable in quality and form for publication on microfilm and electronically: ____________________________________________________________________ ____________________________________________________________________ ____________________________________________________________________ Chair University of California, San Diego 2012 iii TABLE OF CONTENTS Signature Page……………………………………………………………………... iii Table of Contents…………………………………………………………….......... iv List of Figures…………………………………………………………………….… v Abstract……………………………………………………………………………... vii Introduction……………………………………………………………………….… 1 Experimental Procedures……………………………………………………….… 16 Results……………………………………………………………………………… 20 Discussion……………………………………………………………………….…. 32 References……………………………………………………………………….… 36 iv LIST OF FIGURES Figure 1: General schematic diagram of the phosphatidylinositol 3-kinase/Akt signal transduction pathway with targets of Akt and resulting cellular processes.. 3 Figure 2: Schemaric diagram of the non-oxidative branch of the pentose phosphate pathway…………………………………………………………………………… 6 Figure 3: Schematic diagram of the
  • Neuroprotective Sirtuin Ratio Reversed by Apoe4

    Neuroprotective Sirtuin Ratio Reversed by Apoe4

    Neuroprotective Sirtuin ratio reversed by ApoE4 Veena Theendakaraa,1, Alexander Patenta,1, Clare A. Peters Libeua, Brittany Philpota, Sonia Floresa, Olivier Descampsa, Karen S. Poksaya, Qiang Zhanga, Gabriellee Cailinga, Matthew Hartb, Varghese Johna, Rammohan V. Raoa,2,3, and Dale E. Bredesena,c,2,3 aThe Buck Institute for Research on Aging, Novato, CA 94945; bDepartment of Molecular Medicine, University of Texas Health Science Center, San Antonio, TX 78245; and cDepartment of Neurology, University of California, San Francisco, CA 94143 Edited by Solomon H. Snyder, The Johns Hopkins University School of Medicine, Baltimore, MD, and approved September 26, 2013 (received for review July 26, 2013) The canonical pathogenesis of Alzheimer’s disease links the ex- In contrast, cleavage at the α site produces the trophic peptide pression of apolipoprotein E e4 allele (ApoE) to amyloid precursor sAPPα and the inhibitor of APP γ-site cleavage, alpha-COOH- protein (APP) processing and Aβ peptide accumulation by a set of terminal fragment of APP (αCTF) (1, 6). The decision between mechanisms that is incompletely defined. The development of these two proteolytic pathways is governed at least in part by a simple system that focuses not on a single variable but on mul- ligand binding: interaction with the axon guidance and trophic tiple factors and pathways would be valuable both for dissecting factor netrin-1 increases α-site cleavage, whereas interaction with the underlying mechanisms and for identifying candidate thera- the antitrophin Aβ inhibits α-site cleavage and increases net pro- peutics. Here we show that, although both ApoE3 and ApoE4 duction of the four neurite-retractive peptides (1, 6).
  • Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease

    Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease

    cells Review Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease Marta Migocka-Patrzałek * and Magdalena Elias Department of Animal Developmental Biology, Faculty of Biological Sciences, University of Wroclaw, 50-335 Wroclaw, Poland; [email protected] * Correspondence: [email protected] Abstract: Glycogen phosphorylase (PG) is a key enzyme taking part in the first step of glycogenolysis. Muscle glycogen phosphorylase (PYGM) differs from other PG isoforms in expression pattern and biochemical properties. The main role of PYGM is providing sufficient energy for muscle contraction. However, it is expressed in tissues other than muscle, such as the brain, lymphoid tissues, and blood. PYGM is important not only in glycogen metabolism, but also in such diverse processes as the insulin and glucagon signaling pathway, insulin resistance, necroptosis, immune response, and phototransduction. PYGM is implicated in several pathological states, such as muscle glycogen phosphorylase deficiency (McArdle disease), schizophrenia, and cancer. Here we attempt to analyze the available data regarding the protein partners of PYGM to shed light on its possible interactions and functions. We also underline the potential for zebrafish to become a convenient and applicable model to study PYGM functions, especially because of its unique features that can complement data obtained from other approaches. Keywords: PYGM; muscle glycogen phosphorylase; functional protein partners; glycogenolysis; McArdle disease; cancer; schizophrenia Citation: Migocka-Patrzałek, M.; Elias, M. Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease. Cells 1. Introduction 2021, 10, 883. https://doi.org/ The main energy substrate in animal tissues is glucose, which is stored in the liver and 10.3390/cells10040883 muscles in the form of glycogen, a polymer consisting of glucose molecules.
  • A Novel Sirtuin 2 (SIRT2) Inhibitor with P53-Dependent Pro-Apoptotic

    A Novel Sirtuin 2 (SIRT2) Inhibitor with P53-Dependent Pro-Apoptotic

    THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 289, NO. 8, pp. 5208–5216, February 21, 2014 © 2014 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A. A Novel Sirtuin 2 (SIRT2) Inhibitor with p53-dependent Pro-apoptotic Activity in Non-small Cell Lung Cancer*□S Received for publication, August 19, 2013, and in revised form, December 17, 2013 Published, JBC Papers in Press, December 30, 2013, DOI 10.1074/jbc.M113.487736 Gesine Hoffmann‡**, Frank Breitenbücher§, Martin Schuler§¶, and Ann E. Ehrenhofer-Murray‡**1 From the ‡Zentrum fu¨r Medizinische Biotechnologie, Universität Duisburg-Essen, 45117 Essen, Germany, the §Innere Klinik (Tumorforschung), Westdeutsches Tumorzentrum, Universitätsklinikum Essen, 45147 Essen, Germany, the ¶German Cancer Consortium (DKTK) , 69120 Heidelberg, Germany, and the **Humboldt-Universität zu Berlin, Institut fu¨r Biologie, Abteilung Molekulare Zellbiologie, 10115 Berlin, Germany Background: Pharmacological inhibition of the NADϩ-dependent deacetylase SIRT2 holds promise for cancer therapy by preventing deacetylation and inactivation of p53. Results: We identified two novel SIRT2 inhibitors that induce apoptosis in a p53-dependent fashion and activate three p53 target genes. Conclusion: Small-molecule inhibition of SIRT2 activates p53-dependent apoptosis in cancer cells. Significance: The compounds reported here are promising lead candidates for use in cancer treatment. ؉ Sirtuin 2 (SIRT2) is an NAD -dependent protein deacetylase activity (3–5). Sirtuin enzymes have received widespread atten- whose targets include histone H4 lysine 16, p53, and ␣-tubulin. tion over the last few years due to their diverse physiological Because deacetylation of p53 regulates its effect on apoptosis, roles in metabolism, aging, and age-related human disorders pharmacological inhibition of SIRT2-dependent p53 deacetyla- (6–8).
  • Sirtuin 2 Dysregulates Autophagy in High-Fat-Exposed Immune-Tolerant Macrophages

    Sirtuin 2 Dysregulates Autophagy in High-Fat-Exposed Immune-Tolerant Macrophages

    cells Article Sirtuin 2 Dysregulates Autophagy in High-Fat-Exposed Immune-Tolerant Macrophages Sanjoy Roychowdhury 1,†, Anugraha Gandhirajan 1,†, Christopher Kibler 1, Xianfeng Wang 2 and Vidula Vachharajani 1,3,* 1 Department of Inflammation and Immunity, Lerner Research Institute, Cleveland, OH 44195, USA; [email protected] (S.R.); [email protected] (A.G.); [email protected] (C.K.) 2 Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA; [email protected] 3 Department of Critical Care, Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195, USA * Correspondence: [email protected] † These authors contributed equally to the manuscript and should be considered co-1st authors. Simple Summary: SIRT2 regulates autophagy in high-fat-exposed immune cells. Abstract: Obesity increases morbidity and resource utilization in sepsis patients. The immune response in sepsis transitions from an endotoxin-responsive hyper- to an endotoxin-tolerant hypo- inflammatory phase. The majority of sepsis mortality occurs during hypo-inflammation. We reported prolonged hypo-inflammation with increased sirtuin 2 (SIRT2) expression in obese-septic mice. The effect of direct exposure to high-fat/free fatty acid (FFA) and the role of SIRT2 in immune cells during the transition to hypo-inflammation is not well-understood. Autophagy, a degradation process of damaged protein/organelles, is dysregulated during sepsis. Here, we investigated the effect of direct FFA exposure and the role of SIRT2 expression on autophagy as macrophages transition from Citation: Roychowdhury, S.; hyper-to hypo-inflammation. We found, FFA-exposed RAW 264.7 cells with lipopolysaccharide Gandhirajan, A.; Kibler, C.; Wang, X.; (LPS) stimulation undergo endotoxin-sensitive (“sensitive”) hyper- followed by endotoxin tolerant Vachharajani, V.
  • Rats Genetically Selected for High Aerobic Exercise Capacity

    Rats Genetically Selected for High Aerobic Exercise Capacity

    antioxidants Article Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1 1, , 2, 2 3 Terry D. Hinds Jr. * y , Justin F. Creeden y, Darren M. Gordon , Adam C. Spegele , Steven L. Britton 4, Lauren G. Koch 3 and David E. Stec 5,* 1 Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40508, USA 2 Department of Neurosciences, University of Toledo College of Medicine, Toledo, OH 43614, USA; [email protected] (J.F.C.); [email protected] (D.M.G.) 3 Department of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH 43614, USA; [email protected] (A.C.S.); [email protected] (L.G.K.) 4 Department of Anesthesiology, Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA; [email protected] 5 Center for Excellence in Cardiovascular-Renal Research, Department of Physiology & Biophysics, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 392161, USA * Correspondence: [email protected] (T.D.H.J.); [email protected] (D.E.S.) Authors contributed equally. y Received: 24 August 2020; Accepted: 16 September 2020; Published: 19 September 2020 Abstract: Exercise in humans and animals increases plasma bilirubin levels, but the mechanism by which this occurs is unknown. In the present study, we utilized rats genetically selected for high capacity running (HCR) and low capacity running (LCR) to determine pathways in the liver that aerobic exercise modifies to control plasma bilirubin.